Logotype for Corteva Inc

Corteva (CTVA) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Corteva Inc

Q3 2024 earnings summary

9 Jul, 2026

Executive summary

  • Third quarter 2024 results were in line with expectations, with net sales down 10% year-over-year to $2.33B and an operating loss, reflecting challenging dynamics in Latin America and competitive pricing pressures.

  • Crop Protection delivered earnings and margin growth, benefiting from demand for differentiated technology, initial deflation benefits, and volume gains in new products and biologicals.

  • Seed business showed strong year-to-date performance, with pricing gains and share growth in North America, but faced significant declines in Latin America and a Q3 EBITDA loss.

  • Over $400 million in controllable cost savings targeted for 2024, supporting margin stability despite lower revenue expectations.

  • 2025 is expected to return to double-digit operating EBITDA growth and margin expansion, driven by cost improvements, innovation, and a robust product pipeline.

Financial highlights

  • Q3 2024 net sales declined 10% year-over-year to $2.33B; YTD net sales down 4% to $12.93B.

  • Q3 2024 operating EBITDA was $(100)M, with a margin of (4.3)% and a net loss from continuing operations of $519M; YTD operating EBITDA was $2.85B, down 5% year-over-year, with a 22% margin.

  • Q3 2024 GAAP EPS was $(0.76); YTD GAAP EPS was $1.29, down 21% year-over-year.

  • Full-year 2024 net sales guidance updated to $17.0–$17.2B, down 1% at midpoint; operating EBITDA guidance $3.35–$3.45B, up 1% at midpoint.

  • Operating EPS expected at $2.50–$2.60, down 5% year-over-year; free cash flow guidance reaffirmed at $1.5–$2.0B.

Outlook and guidance

  • 2024 full-year EBITDA margin expected at ~20%, with free cash flow conversion rate of 45%–50%.

  • 2025 preliminary outlook: net sales $17.3–$17.7B, operating EBITDA $3.6–$4.0B, with double-digit EBITDA growth and margin expansion.

  • Seed pricing expected to grow low single digits; crop protection industry expected to be flat in 2025.

  • $400M in cost improvements anticipated for 2025, with continued benefits from deflation and productivity.

  • Guidance excludes impacts from extreme weather, major operational disruptions, or further macroeconomic shocks.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more